Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 Industry Snapshot
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Value of Health
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Workforce Training Center at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Week 2022
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Certara

Life Sciences | Drug Development
Princeton, NJ (888) 708-7444 Website LinkedIn

Overview

At Certara, we accelerate medicines to patients, partnering with life science innovators.  Together with our partners, we use biosimulation and technology-enabled services to transform drug discovery and development.

Our integrated and proprietary end-to-end platform with biosimulation, regulatory science, and market access solutions combined with our 900 strong team of scientists and subject matter experts enable informed decision-making, higher R&D productivity, and improved patient outcomes.  With our quantitative approach, we address your critical drug discovery and development decisions:

How can dosing be optimized to maximize safety and efficacy?

What is the probability of clinical trial success?

How do we work with regulatory agencies to steer through uncertainty?

What’s the best way to assess and demonstrate maximum value of a new therapy?

Certara works across all therapeutic areas and innovative therapies, including immuno-oncology, rare disease, CNS, respiratory disease, gene therapy, and global health, providing translational solutions from discovery to patient access.

Learn more: https://www.certara.com/company/our-story/ 

Company News

News

Certara Blog: A Day in the Life of a Clinical Pharmacology Consultant

Oct 26, 2021

Posted by Certara

Whitepapers

Considerations for Managing Clinical Trials and Regulatory Filing Strategy During COVID-19

Apr 15, 2021

Posted by Certara

Company Events

Seminars

Certara Webinar Presents: SEND Webinar Series 2023 Session 1

Mar 30, 2023

Posted by Certara

Seminars

Certara Webinars Presents: The Application of Model-Informed Drug Development in Rare Disease Development

Apr 03, 2023

Posted by Certara

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2023 All Rights Reserved